CompletedNot Applicable

MRI for Screening and Monitoring Scleroderma ILD

United States25 participantsStarted 2022-05-01

Plain-language summary

The purpose of this study is to test MRI methods for evaluating patients with Scleroderma-associated interstitial lung disease.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Previous clinical or echocardiographic evidence of significant right heart failure
✕. History of right heart catheterization showing a cardiac index ≤ 2 l/min/m²
✕. PAH requiring parenteral therapy with epoprostenol/treprostinil

Presence of ILD on CT and MRI

Timeframe: Baseline

Change in RBC/Barrier Ratio

Timeframe: 6 months

NCT IDNCT05204355

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-31